Immunotherapy first: landmark trial tests delayed kidney surgery for advanced cancer
NCT ID NCT03977571
First seen May 11, 2026 · Last updated May 18, 2026 · Updated 3 times
Summary
This study is for people with kidney cancer that has spread to other parts of the body. It compares two approaches: having surgery to remove the kidney tumor after initial immunotherapy, versus not having surgery at all. The goal is to see if delayed surgery helps patients live longer. About 400 adults with intermediate or poor-risk disease will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Oncology, Aarhus University Hospital
RECRUITINGAarhus, Central Region of Denmark, 8200, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Oncology, Herlev Hospital
RECRUITINGHerlev, 2730, Denmark
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
Department of Oncology, Odense University Hospital
RECRUITINGOdense, 5000, Denmark
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
Department of Oncology, Stavanger Universitetssykehus
RECRUITINGStavanger, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Department of Oncology, Ålesund Universitetsykehus
RECRUITINGÅlesund, Norway
Contact Email: •••••@•••••
Contact
-
Department of Urology, Haukeland University Hospital
RECRUITINGBergen, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.